Overview

Follicle Size and Oocyte Development

Status:
Recruiting
Trial end date:
2021-08-01
Target enrollment:
0
Participant gender:
Female
Summary
Studies have shown that the follicles greater in diameter was most likely to have a mature oocyte that was capable of fertilization and best suited for development into a high-quality embryo. Smaller follicles showed lower rates ( 60%). Lately new triggering protocols have emerged aiming to improve the proportion of mature oocytes at the time of retrieval. The aim of this study is to learn the effects of the dual triggering compared to the standard hCG triggering on the oocyte development and quality as a function of the follicle size
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Sheba Medical Center
Treatments:
Chorionic Gonadotropin
Triptorelin Pamoate
Criteria
Inclusion Criteria:

1. Age- 18-45

2. Antagonist protocol

3. Triggering: A- with Ovitrelle ( HCG) 250 mcg B- with dual triggering - Ovitrelle (
HCG) 250 mcg + Decapeptyl ( GnRH Agonist ) 0.1 mg*2

Exclusion Criteria:

1. Endometriosis

2. Known mutation of Fragile X